Ocular Therapeutix's total assets for Q4 2025 were $808.06M, an increase of 96.66% from the previous quarter. OCUL total liabilities were $153.75M for the fiscal quarter, a 0.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.